Loading...

ACTR-79. ESTABLISHMENT OF CLINICAL PROTOCOL TARGETING CANCER STEM CELLS IN RECURRENT GLIOBLASTOMA USING HIGH-THROUGHPUT DRUG SCREENING

Despite aggressive multimodal oncological treatment, glioblastoma (GBM) disease progresses within 10 months. Due to the lack of treatment options for the relapsed disease, enrollment in clinical trials may be the best option. However, the fundamental preclinical studies leading to clinical investiga...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Neuro Oncol
Main Authors: Skaga, Erlend, Kulesskiy, Evgeny, Brynjulfsen, Marit, Sandberg, Cecilie Jonsgar, Kyttälä, Aija, Langmoen, Iver Arne, Laakso, Aki, Gaál-Paavola, Emília, Perola, Markus, Wennerberg, Krister, Vik-Mo, Einar Osland
Format: Artigo
Sprog:Inglês
Udgivet: Oxford University Press 2017
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692302/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.066
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!